http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108472285-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5244fd7f668d629fc7578ddd681518d6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
filingDate 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408e5be718553851309add97d3ddeee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b10ad52a73f4d8edd9028900be9bc61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8300b6d48c94147955833e46f00ce7f7
publicationDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108472285-A
titleOfInvention Diaryl and arylheteroaryl urea derivatives for the prevention and treatment of hallucinations associated with neurodegenerative diseases
abstract The present invention relates to certain pyrazole derivatives with formula (I) and pharmaceutical compositions thereof which regulate the activity of 5-HT 2A serotonin receptors, and their use in the treatment and prevention of visual hallucinations associated with dementia with Lewy bodies use.
priorityDate 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014085362-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015085004-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466615674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465455097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466715592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163769205

Total number of triples: 34.